Categories
Fruits & Vegetables

Tart Cherries

[amazon_link asins=’B000I6625I,B000I6625I’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’71a1e85d-0996-11e7-822a-3794872c2172′]

Bing cherry branch
Image via Wikipedia

Botanical Name:Prunus cerasus
Other names: Prunus cerasus, sour cherry, pie cherry, tart cherry juice, montmorency cherry, balaton cherry.

Cherries are the smallest members of the stone fruit family, which include plums, apricots, nectarines, and peaches.

Cherrries are typically classified as either sweet or tart. Sweet cherries include Bing cherries, Lambert cherries, Rainier cherries and are grown mainly in Washington, Oregon and Idaho. Tart cherries include the Montmorency and Balaton varieties and are produced primarily in Michigan.

Medicinal Uses:Both sweet and tart cherries and cherry juice have long been used by traditional healers as a folk remedy for gout, because cherries are thought to lower urate levels in the body.

Tart cherries are used for conditions involving inflammation and pain, such as:
arthritis

*Gout

*Muscle pain

*Back pain

*Diabetes

Neurodegenerative diseases
Both sweet and tart cherries contain phenolics, naturally-occurring plant compounds that have anti-inflammatory, antioxidant effects.

The main type of phenolic in cherries is called anthocyanins. In general, the darker the cherry color, the higher the anthocyanin content.

Anthocyanins have been found to block two enzymes, COX-1 and COX-2, which play a role in the production of inflammatory compounds called prostaglandins. Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) such as naproxen and ibuprofen also work this way.

In test tube studies, cherry anthocyanins have been found to protect neurons from damage by oxidative stress. However, there have been no studies that have looked at whether cherry extracts could prevent or slow the progression of neurodegenerative diseases such as Alzheimer’s disease or Parkinson’s disease in humans.

Both Balaton and Montmorency tart cherries contain relatively high levels of the antioxidant melatonin compared to other foods. Montmorency cherries contain approximately 6 times more melatonin than do Balaton cherries.

Are tart cherries more effective than sweet cherries?
Generally, tart cherries have been found to have higher concentrations of phenolics and anthocyanins than sweet cherries.

Tart cherries are also slightly lower in sugar. Half a cup of sweet cherries contains 9.3 g of sugar and 46 calories, compared to 6.6 g of sugar and 39 calories in tart cherries.

However, there is no real evidence that these differences are significant-both types of cherries are very high in anthocyanins compared with other foods.

It may be that we are hearing more about the health benefits of tart cherries because of the way they are marketed. In 2005, the US Food and Drug Administration sent warning letters to 29 cherry farmers and distributors for positioning tart cherries on their websites as a medicinal food that could possibly help people with gout, arthritis, diabetes, and prevent cancer.

You may click to see:->Tart cherries may help reduce type 2 diabetes, heart disease risk

Tart Cherries Reduce Inflammation and Improve General Health

Natural Painkillers And Strong Antioxidants Found In Tart Cherries

TART CHERRIES contain antioxidant compounds 10 times more active than aspirin.

What research has been done on tart cherries?
Although anthocyanins, which are also found in blueberries and other purplish-red fruits and vegetables, are known to be powerful antioxidants, no studies have looked at whether cherries–tart or sweet–can relieve symptoms of arthritis, gout, or diabetes outside the lab.

All studies involving cherries have been very small, so we’ll have to wait to see whether tart cherries are beneficial and in what quantities. In the meantime, here are a few of the studies that have been conducted so far:
A small randomized controlled trial in the British Journal of Sports Medicine examined the effectiveness of a tart cherry juice blend in preventing symptoms of exercise-induced muscle damage. Fourteen male college students drank 12 fl oz of a cherry juice blend or a placebo, twice per day for eight consecutive days. Strength loss was significantly lower in people taking the cherry juice (4%) compared with the placebo (22%). Pain was also significantly lower in people taking the cherry juice.

Jill M. Tall, Ph.D., research fellow at Johns Hopkins, was the lead researcher of a study that tested the effectiveness of orally administrated anthocyanins from tart cherries on inflammation-induced pain in rats. The results of the study suggested that tart cherry anthocyanins may have a beneficial role in reducing inflammatory pain.

One small study published in the Journal of Nutrition supported the anti-gout effectiveness of cherries. assessed the effects of Bing cherry (a sweet cherry) consumption on healthy women and found that cherry consumption decreased blood urate levels, and there was a marginal decrease in inflammatory markers c-reactive protein and nitric oxide.

Safety
Cherries contain sorbitol, which may exacerbate symptoms in people with irritable bowel syndrome, small intestine bacterial overgrowth, or fructose malabsorption.

Where to find tart cherries
Tart cherry juice and fresh, frozen or dried tart cherries can be found in grocery stores, health food stores, and online.

Sources:http://altmedicine.about.com/od/completeazindex/a/tart_cherry.htm

Reblog this post [with Zemanta]
Categories
News on Health & Science

Plastic Bottles are Deadly for Your Brain

[amazon_link asins=’B01G7I2X62,B01EUUFGHM,B00AL1EUAO,B00WH2NKRO,B00WH1RTTU,B00XC9OEYE,B01DUWYCGW,B01NCKPTLT’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’faa77bca-402f-11e7-92b1-c7a762730f75′]

[amazon_link asins=’B00PYS00Q2,B01BYA4H1W,B01JCNEJHU,B01MD15C4O,B00TT70OME,B01K7OKGQ6,B01ASDODYC,B0128YT76S,B01EFFYTQG’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’c45e8a80-402f-11e7-8f99-cfdc0e45522a’]

Plastic containers may be deadly for your brain. Canadian researchers have found that Bisphenol A (BPA), the chemical used in making plastic containers, might be responsible for impairing many brain functions such as learning and remembering.

………………..

They also fear that it could be a factor behind Alzheimer’s, schizophrenia and depression.

BPA is globally used in making plastic water bottles, baby food bottles, food containers and dental prostheses.

In their study, the researchers at the University of Guelph near here found that BPA might be leaking into the solid or liquid foods kept in the plastic containers.

When these foods and liquids are consumed, they said, the chemical might be getting into the human system, disrupting communication between brain neurons which is vital in understanding and remembering.

According to researcher Neil MacLusky, the slow doses of this chemical badly impair the formation of synapses in the areas of the human brain linked to learning.

As part of their study, the researchers fed African green monkeys at St. Kitts Island with foods containing low levels of BPA for a month.

After that period, they found that the chemical had slowed down the synapses in the monkey brain.

MacLusky said this process was linked to the hormone oestrogen.

“Oestrogen enhances the rate at which some types of synapses are formed and is vital in maintaining normal neuronal structure in regions of the brain that control learning, memory and mood state,” he said in a TV interview.

When monkeys had BPA in their system, he said, it seriously impaired this process, affecting their ability to remember.

Sources: The Times Of India

Reblog this post [with Zemanta]
Categories
Suppliments our body needs

DHEA (Dehydroepiandrosterone)

[amazon_link asins=’B00005TP4H,B00UXLUFJ2,B001G7QVWC,B0016QTR10,B016NJL3Y8,B00YD2FB1Y,B01K2GYI04,B004BZJCU4,B01DOFXJZK’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’adef7afc-4cd4-11e7-a2ee-1f1836e34e19′]

Other names: dehydroepiandrosterone, dehydroepiandrosterone sulfate

Synonyms and brand names:
Synonyms for Dehydroepiandrosterone are: Dehydroisoandrosterone; 3?-Hydroxy-5-androsten-17-one; 3?-Hydroxyandrost-5-en-17-one; Dehydroisoandrosterone; Hydroxyandrost-5-en-17-one; Prasterone; trans-Dehydroandrosterone.

Brand names for DHEA include Prastera, Fidelin and Fluasterone; supplement versions are manufactured from wild Mexican yam.

Definition: Dehydroepiandrosterone (DHEA) is a natural steroid prohormone produced from cholesterol by the adrenal glands, the gonads, adipose tissue, brain and in the skin (by an autocrine mechanism).The body converts DHEA to male and female sex hormones. DHEA is the precursor of androstenedione, which can undergo further conversion to produce the androgen testosterone and the estrogens estrone and estradiol. DHEA is also a potent sigma-1 agonist.

DHEA levels typically peak by the time people are in their 20s and decline with age, which is why there has been considerable interest in DHEA and its role in aging. In fact, DHEA supplements have been touted as an anti-aging hormone because lower levels of DHEA have been reported in some people with type 2 diabetes, breast cancer, heart disease, osteoporosis, AIDS, adrenal insufficiency, kidney disease and anorexia. Certain medications may also deplete DHEA, such as corticosteroids, insulin, opiates and danazol.

DHEA is manufactured naturally in the body, but DHEA supplements can also be made in a laboratory from a substance called diosgenin, found in soybeans and wild yam. Wild yam cream and supplements are often promoted as being a natural source of DHEA, but the body can’t convert wild yam to DHEA on its own — the conversion must be done in a laboratory.

……………….

Dehydroepiandrosterone sulfate
Dehydroepiandrosterone sulfate (DHEAS) is the sulfated version of DHEA. This conversion is reversibly catalyzed by sulfotransferase (SULT2A1) primarily in the adrenals, the liver, and small intestine. In the blood, most DHEA is found as DHEAS with levels that are about 300 times higher than those of free DHEA. Orally-ingested DHEA is converted to its sulfate when passing through intestines and liver. Whereas DHEA levels naturally reach their peak in the early morning hours, DHEAS levels show no diurnal variation. From a practical point of view, measurement of DHEAS is preferable to DHEA, as levels are more stable.

Production:DHEA is produced from cholesterol through two cytochrome P450 enzymes. Cholesterol is converted to pregnenolone by the enzyme P450 scc (side chain cleavage); then another enzyme, CYP17A1, converts pregnenolone to 17?-Hydroxypregnenolone and then to DHEA. In humans, DHEA is the dominant steroid hormone and precursor of all sex steroids.

Note : DHEA can be synthesized in a laboratory using wild yam extract. However, it is believed that wild yam cannot be converted into DHEA by the body. Therefore, information that markets wild yam as a “natural DHEA” may be inaccurate.

Role
DHEA can be understood as a prohormone for the sex steroids. DHEAS may be viewed as buffer and reservoir. As most DHEA is produced by the zona reticularis of the adrenal, it is argued that there is a role in the immune and stress response.[who?]

As almost all DHEA is derived from the adrenal glands, blood measurements of DHEAS/DHEA are useful to detect excess adrenal activity as seen in adrenal cancer or hyperplasia, including certain forms of congenital adrenal hyperplasia. Women with polycystic ovary syndrome tend to have elevated levels of DHEAS.

Evidence
These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider.

Uses based on scientific evidence Grade:-
Adrenal insufficiency
Several studies suggest that DHEA may improve well-being, quality of life, exercise capacity, sex drive, and hormone levels in people with insufficient adrenal function (Addison’s disease). Though promising, additional study is needed to make a strong recommendation. Adrenal insufficiency is a serious medical condition and should be treated under the supervision of a qualified healthcare professional, including a pharmacist.

Depression
The majority of clinical trials investigating the effect of DHEA on depression support its use for this purpose under the guidance of a specialist. Further research is needed to confirm these results.

Obesity
The majority of clinical trials investigating the effect of DHEA on weight or fat loss support its use for this purpose. Further research is needed to confirm these results.

Systemic lupus erythematosus
The majority of clinical trials investigating the effect of DHEA for systemic lupus erythematosus support its use as an adjunct treatment. Additional study is needed to confirm these results.

Aging
DHEA may offer some benefit to individuals in terms of aging. Small increases in bone mineral density have been seen, but more study is needed to confirm these findings.

Alzheimer’s disease
Initial research reports that DHEA does not significantly improve cognitive performance or change symptom severity in patients with Alzheimer’s disease, but some experts disagree. Additional study is warranted in this area.

Bone density
The ability of DHEA to increase bone density is under investigation. Effects are not clear at this time.

Cardiovascular disease
Initial studies report possible benefits of DHEA supplementation in patients with cholesterol plaques (“hardening”) in their arteries. There is conflicting scientific evidence regarding the use of DHEA supplements in patients with heart failure or diminished ejection fraction. Other therapies are more proven in this area, and patients with heart failure or other types of heart disease should discuss treatment options with a cardiologist.

Cervical cancer
Initial research reports that the use of intravaginal DHEA may be safe and may promote regression of low-grade cervical lesions. However, further study is necessary in this area before a firm conclusion can be drawn. Patients should not substitute the use of DHEA for more established therapies, and they should discuss management options and follow-up with a primary healthcare professional or gynecologist.

Chronic fatigue syndrome
The scientific evidence remains unclear regarding the effects of DHEA supplementation in patients with chronic fatigue syndrome. Better research is necessary before a clear conclusion can be drawn.

Cocaine withdrawal
Preliminary study shows that DHEA is not beneficial in treating cocaine dependence, but further study is needed before a firm conclusion can be drawn.

Critical illness
Unclear scientific evidence exists surrounding the safety or effectiveness of DHEA supplementation in critically ill patients. At this time, it is recommended that severe illness in the intensive care unit be treated with more proven therapies.

Crohn’s disease
Initial research reports that DHEA supplements are safe for short-term use in patients with Crohn’s disease. Preliminary research suggests possible beneficial effects, although further research is necessary before a clear conclusion can be drawn.

Dementia
Early evidence gives conflicting results as to whether DHEA offers benefit to individuals with dementia.

Heart failure
There is conflicting scientific evidence regarding the use of DHEA supplements in patients with heart failure. Other therapies are proven in this area, and patients with heart failure or other types of heart disease should discuss treatment options with a cardiologist.

HIV/AIDS
Although some studies suggest that DHEA supplementation may be beneficial in patents with HIV, results from different studies do not agree with each other. There is currently not enough scientific evidence to recommend DHEA for this condition, and other therapies are more proven in this area.

Induction of labor
Preliminary evidence suggests that DHEA may help to induce labor. Further research is needed and people who are pregnant should not self-treat.

Infertility
DHEA supplementation may be beneficial in women with ovulation disorders. There is currently not enough scientific evidence to form a clear conclusion about the use of DHEA for this condition.

Menopausal disorders
Many different aspects of menopause have been studied using DHEA as a treatment, such as vaginal pain, osteoporosis, hot flashes, emotional disturbances such as fatigue, irritability, anxiety, depression, insomnia, difficulties with concentration and memory, or decreased sex drive (which may occur near the time of menopause). Study results disagree and additional study is needed in this area.

Myotonic dystrophy
There is conflicting scientific evidence regarding the use of DHEA supplements for myotonic dystrophy. Better research is necessary before a clear conclusion can be drawn.

Ovulation disorders
Low-quality studies suggest that DHEA supplements may benefit women with ovulation disorders. However, results of research in this area are conflicting, and safety is not established.

Partial androgen deficiency

Restoring DHEA levels to young adult values seems to benefit the age-related decline in physiological functions. However, additional study is required to confirm these preliminary results.

Psoriasis
Study results suggest that DHEA offers no benefit to individuals with psoriasis, but some disagree. Additional study is needed before a firm recommendation can be made.

Rheumatoid arthritis
Preliminary evidence from a case series suggests that DHEA likely offers no benefit to individuals with rheumatoid arthritis. Well-designed clinical trials with appropriate endpoints are required before a strong recommendation can be made.

Schizophrenia
Initial research reports benefits of DHEA supplementation in the management of negative, depressive, and anxiety symptoms of schizophrenia. Some of the side effects from prescription drugs used for schizophrenia may also be relieved. Further study is needed to confirm these results before a firm conclusion can be drawn.

Septicemia (serious bacterial infections in the blood)

Unclear scientific evidence exists surrounding the safety or effectiveness of DHEA supplementation in septic patients. At this time, more proven therapies are recommended.

Sexual function / libido / erectile dysfunction
The results of studies vary on the use of DHEA in erectile dysfunction and sexual function, in both men and women. Better research is necessary before a clear conclusion can be drawn.

Sjogren’s syndrome
DHEA showed no evidence of efficacy in Sjogren’s syndrome in preliminary study. Without evidence for efficacy, patients with Sjogren’s syndrome should avoid using unregulated DHEA supplements, since long-term adverse consequences of exposure to this hormone are unknown. Further research is needed in this area.

Skin aging
Preliminary study suggests the possibility of using DHEA topically as an anti-skin aging agent. Further research is needed to confirm these results.

Fibromyalgia (postmenopause)
DHEA does not seem to improve quality of life, pain, fatigue, cognitive function, mood, or functional impairment in fibromyalgia.

Immune system stimulant
It is suggested by some textbooks and review articles that DHEA can stimulate the immune system. However, current scientific evidence does not support this claim.

Memory
Studies of the effects of dehydroepiandrosterone (DHEA) on cognition have produced complex and inconsistent results. Additional study is warranted in this area.

Muscle strength
Many study results in this area conflict but overall the current available evidence in this area is negative. Further research is needed before firm conclusions can be drawn

Disputed effects
In the United States, DHEA or DHEAS have been advertised with claims that they may be beneficial for a wide variety of ailments. DHEA and DHEAS are readily available in the United States, where they are marketed as over-the-counter dietary supplements. A 2004 review in the American Journal of Sports Medicine concluded that “The marketing of this supplement’s effectiveness far exceeds its science.” Because DHEA is converted to androstenedione and then testosterone, it has two chances to aromatize into estrogen- estrone from androstenedione, and estradiol from testosterone. As such, it is possible for increases in estrogen levels more than testosterone in men.

Increasing endogenous production
Regular exercise is known to increase DHEA production in the body. Caloric restriction has also been shown to increase DHEA in primates. Some theorize that the increase in endogenous DHEA brought about by caloric restriction is partially responsible for the longer life expectancy known to be associated with caloric restriction

Legality
DHEA supplements were taken off the U.S. market in 1985 because of concerns about false claims regarding its benefits. It became available only by prescription but was reintroduced as a nutritional supplement after the Dietary Supplement Health and Education Act was passed in 1994.

United States
A bill has been introduced, in March 2007, in the U.S. Senate (S. 762) that attempts to classify DHEA as a controlled substance under the category of anabolic steroids. The sponsor is Charles Grassley (R-IA). The cosponsors are Richard Durbin (D-IL), and John McCain (R-AZ).[30] This bill was referred to the Senate Judiciary Committee. Then in December 2007, Charles Grassley introduced the “S. 2470: Dehydroepiandrosterone Abuse Reduction Act of 2007,” in an attempt to amend the Controlled Substances Act to make “unlawful for any person to knowingly selling, causing another to sell, or conspiring to sell a product containing dehydroepiandrosterone to an individual under the age of 18 years, including any such sale using the Internet,” without a prescription. The bill was read twice and referred to the Senate Judiciary Committee.

Canada
In Canada, a prescription is required to buy DHEA

Resources:
http://en.wikipedia.org/wiki/Dehydroepiandrosterone
http://altmedicine.about.com/od/dhea/a/dhea.htm

Reblog this post [with Zemanta]
Categories
News on Health & Science

Diabetics, Beware

 

U[amazon_link asins=’B016YOCSIC,B00024D7RW,1580405584,B002Z8WDVO,B0089LOG7U,0544302133,B01IAILDKY,B06VWGPCPP,B00N3JOCOU’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’5763b489-a027-11e7-9593-3dd3d201fd52′]S scientists have found a link between high blood sugar levels and Alzheimer’s.

It’s a puzzle that has baffled scientists for long. The brain, which has an impenetrable protective layer around it in the form of a thick blood-brain barrier, should not be affected that easily by the chemical changes taking place elsewhere in the body. The blood-brain barrier, composed of tightly packed cells, insulates the brain from an overload of undesirable chemicals that circulate in the bloodstream, while still allowing the essential metabolic functions.

This is thought to be true in the case of blood sugar as well. Diabetes patients, who have high levels of glucose in their blood because of faulty insulin production, normally have near-normal glucose levels in the blood circulating through the myriad blood vessels in the brain.

Yet scientists have found that 30 to 65 per cent of diabetics run the risk of developing Alzheimer’s disease — a debilitating degenerative brain disorder that severely impairs cognitive function and memory — in their old age. The connection between the two, though circumstantial, has so far perplexed researchers.

The issue is of critical importance to India which may soon be the diabetes capital of the world. With the number of diabetes cases in the country rising, there may be an increase in the occurrence of Alzheimer’s disease, as has been happening in the West. Despite being the focus of the medical world for long, there is no cure for this severest form of dementia.

But a team of researchers at the Salk Institute of Biological Studies in the US seems to have resolved the puzzle. The scientists, led by David Schubert, claim to have found a molecular basis for the diabetes-Alzheimer’s interaction.

Though the brain remains largely insulated from the high blood sugar otherwise found in the body, the layers of the blood-brain barrier — which is composed of cells that are more densely packed than elsewhere in the body — are often exposed to the high blood sugar. As a result, the central nervous system is indirectly affected, scientists hypothesise.

To investigate this, Schubert — a professor at the institute’s Cellular Neurobiology Laboratory — and his colleagues studied the blood vessels in the brain of young mice that were rendered diabetic. The study, reported in the latest issue of Neurobiology of Aging, looked specifically at the interaction between the elevated blood glucose levels and beta-amyloid — protein molecules that clump together to form the senile plaques that riddle Alzheimer’s patients’ brains.

To their surprise, the scientists found that despite having beta-amyloid in very low levels — not enough to trigger the brain disorder — the mice began suffering from significant memory loss. They also noticed an increase in inflammation in the brain. “The damage took place long before the first plaques appeared,” says Schubert.

The mice suffered damage to the blood vessels well before any overt signs of Alzheimer’s — such as nerve cell death or the acquisition of amyloid deposits, the hallmark of the disease — could be detected in their brains. Further experiments revealed that the vascular damage was due to the overproduction of free radicals, resulting in oxidative damage to the cells lining the brain’s blood vessels.

“Because of the elevated blood glucose in diabetes, the blood vessels of the brain become damaged. This damage will lead to more stress in the brain because the availability of nutrients in the blood is reduced. Since nerve cells in the early stages of Alzheimer’s disease are themselves weakened, the additional stress of a poor nutrient supply may lead to their premature death, resulting in early onset of Alzheimer’s,” Schubert told KnowHow.

According to Joseph Burdo, co-author of the study, researchers earlier could not find a link between the two because they were looking for a direct connection between an impaired insulin signalling and Alzheimer’s, which never existed. “Many studies have focused on altered insulin signalling in the brain as a possible mechanism for the association between Alzheimer’s disease and diabetes but researchers paid much less attention to the impact of increased blood glucose levels on brain function and the pathogenesis of Alzheimer’s,” explains Burdo.

While it is normal for a person to have a low level of amyloid circulating in his or her blood, in diabetics there may be a synergistic toxicity between the amyloid and high level of blood glucose which comes in the way of proper blood vessel formation, says Burdo.

Anoop Misra, who heads the department of diabetes and metabolism at the Fortis Group of Hospitals, New Delhi, says that though it is too early to say the study may have any clinical significance, there is a lesson to take home. “If you could keep your blood sugar well under control, you can deal with two monsters — diabetes and Alzheimer’s.”

And that would be much like the proverbial stone that can kill two birds with one shot.

Turmeric helps
While there is no clear-cut study to establish the prevalence of Alzheimer’s disease in the Indian population, scientists infer that cases of the neurodegenerative disease may be far fewer in India than in the West despite increased life expectancy because of the amount of haldi (turmeric) Indians consume. A team of researchers at the Salk Institute of Biological Sciences in the US has now discovered that a downstream derivative of curcumin, the active ingredient in turmeric, does enhance cognition and memory. In a recent work published in Neurobiology of Aging, the scientists report isolation of the compound (called CNB-001), saying that it boosts communication between brain cells, facilitating long-term retention of memory. They feel that it could be a potential remedy for treating brain disorders affecting memory and cognition such as Alzheimer’s and Parkinson’s disease.

Sources: The Telegraph (Kolkata, India)

Zemanta Pixie
Categories
Featured

Why Low Cholesterol is NOT Good For You

[amazon_link asins=’B015RZ8OXM,B002CQU52I,B0037XNQ4O,B00I07Y1LY,B007PM4KPW,B00XLXA508,B00THDTU2K,B00HY0NXPI,B00WFGPAKW’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’38233400-6c3f-11e7-9407-3fd4f113db52′]

Too little of one type of cholesterol has been linked to memory loss and Alzheimer’s disease.

click & see

Scientists studied more than 3,500 civil servants to investigate how levels of HDL or “good” cholesterol were associated with memory. HDL cholesterol can influence the formation of the beta-amyloid “plaques” that are a distinctive feature in the brains of Alzheimer’s patients.

Higher levels of HDL are also believed to protect against damage to blood supply caused by the narrowing of the arteries.

After the five-year study period, the researchers found that people with low levels of HDL were 53 percent more likely to suffer memory loss than people with the highest levels of HDL.

Those with impaired memory are at an increased risk of developing dementia later in life.
You may click to see:->What is the normal level of cholesterol?
Sources:

* BBC News June 30, 2008

* Arteriosclerosis, Thrombosis, and Vascular Biology June 30, 2008

css.php